Literature DB >> 25710663

Trends in the proportion of patients with lung cancer meeting screening criteria.

Yi Wang1, David E Midthun2, Jason A Wampfler3, Bo Deng4, Shawn M Stoddard4, Shuo Zhang4, Ping Yang4.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25710663      PMCID： PMC4493881          DOI： 10.1001/jama.2015.413

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Cynthia L Leibson; Barbara P Yawn; L Joseph Melton; Walter A Rocca
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  Cancer statistics, 2014.

Authors:  Rebecca Siegel; Jiemin Ma; Zhaohui Zou; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-01-07       Impact factor: 508.702

3.  Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391
  3 in total
  22 in total

1.  Editorial commentary: meeting a paramount challenge.

Authors:  Ping Yang
Journal:  Transl Lung Cancer Res       Date:  2018-04

2.  Sputum-based DNA methylation biomarkers to guide lung cancer screening decisions.

Authors:  Delphine Lissa; Ana I Robles
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

3.  Proportion of Non-Small-Cell Lung Cancer Patients that Would Have Been Eligible for Lung Cancer Screening.

Authors:  Geena X Wu; Leanne Goldstein; Jae Y Kim; Dan J Raz
Journal:  Clin Lung Cancer       Date:  2016-01-14       Impact factor: 4.785

4.  5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study.

Authors:  Yung-Hung Luo; Lei Luo; Jason A Wampfler; Yi Wang; Dan Liu; Yuh-Min Chen; Alex A Adjei; David E Midthun; Ping Yang
Journal:  Lancet Oncol       Date:  2019-06-26       Impact factor: 41.316

Review 5.  Lung cancer screening in patients with chronic obstructive pulmonary disease.

Authors:  Jessica Gonzalez; Marta Marín; Pablo Sánchez-Salcedo; Javier J Zulueta
Journal:  Ann Transl Med       Date:  2016-04

6.  Trends in Subpopulations at High Risk for Lung Cancer.

Authors:  Ping Yang; Yi Wang; Jason A Wampfler; Dong Xie; Shawn M Stoddard; Jun She; David E Midthun
Journal:  J Thorac Oncol       Date:  2016-02       Impact factor: 15.609

7.  Incorporating both genetic and tobacco smoking data to identify high-risk smokers for lung cancer screening.

Authors:  Guochong Jia; Wanqing Wen; Pierre P Massion; Xiao-Ou Shu; Wei Zheng
Journal:  Carcinogenesis       Date:  2021-06-21       Impact factor: 4.944

8.  Characterizing phenotypic abnormalities associated with high-risk individuals developing lung cancer using electronic health records from the All of Us researcher workbench.

Authors:  Jie Na; Nansu Zong; Chen Wang; David E Midthun; Yuan Luo; Ping Yang; Guoqian Jiang
Journal:  J Am Med Inform Assoc       Date:  2021-10-12       Impact factor: 7.942

9.  Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.

Authors:  Rafael Meza; Jihyoun Jeon; Iakovos Toumazis; Kevin Ten Haaf; Pianpian Cao; Mehrad Bastani; Summer S Han; Erik F Blom; Daniel E Jonas; Eric J Feuer; Sylvia K Plevritis; Harry J de Koning; Chung Yin Kong
Journal:  JAMA       Date:  2021-03-09       Impact factor: 157.335

Review 10.  The role of gender in non-small cell lung cancer: a narrative review.

Authors:  Ioana Baiu; Ashley L Titan; Linda W Martin; Andrea Wolf; Leah Backhus
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.